Trials / Completed
CompletedNCT04530591
User Acceptability of a Device-Based Opioid Overdose Intervention
A Proof of Concept, Randomized, Single Center Study on Frameworks for Wearable Devices to Sense and Respond to Opioid Overdoses
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 97 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This pilot study evaluates the needs of opioid users for a device-based intervention for opioid overdoses. The results of this one-time short questionnaire will inform development of a novel naloxone delivery device.
Detailed description
All opioid overdose related deaths can be prevented with the timely delivery of Naloxone. This study is a one-time, preliminary survey of participants with opioid use disorder to assess the need for, and community attitudes towards, a wearable device capable of autonomously detecting and responding to an opioid overdose. The results of this survey will be used to guide ongoing development of a de novo device. This study will be conducted over a 3 month period and survey participants from the Kensington Neighborhood in North Philadelphia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Survey | Participants will complete a survey about their opioid use history, its impact on their lives, their current strategies for preventing or reversing opioid overdoses, and their preferences for a device-based intervention. |
| OTHER | Interview | Participants will participate in a semi-structured interview, during which they will provide feedback on non-functional, "looks-like" prototypes of a naloxone delivery device. |
Timeline
- Start date
- 2020-08-25
- Primary completion
- 2020-09-15
- Completion
- 2020-09-15
- First posted
- 2020-08-28
- Last updated
- 2021-07-07
- Results posted
- 2021-07-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04530591. Inclusion in this directory is not an endorsement.